Dipti Kumar, MD
Obstetrics & Gynecology · Washington, DCNPI 1245678002
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,178 of the $3,190 with a category attached, or 68.3%. 26 manufacturers reported payments, led by Scynexis, Inc. at 37.1% of the total. Reporting peaked in 2022 at $1,361 and has fallen 68.7% since, to $426 in 2025. Among obstetrics & gynecology clinicians in DC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 102 payments — averaging $31.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Scynexis, Inc.$1K
- Organon$263
- Daiichi Sankyo Inc.$181
- AbbVie$173
- Viiv Healthcare Company$136
- Astellas Pharma US Inc$129
- plus $1K from 20 others
What the payments were for
- Consulting fees$1,00031%
- Food & beverage$2,17868%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Scynexis, Inc. | 5 | $1,183 |
| Organon | 9 | $263 |
| Daiichi Sankyo Inc. | 9 | $181 |
| AbbVie | 10 | $173 |
| Viiv Healthcare Company | 5 | $136 |
| Astellas Pharma US Inc | 6 | $129 |
| Aspira Women's Health Inc | 4 | $104 |
| Therapeuticsmd, Inc. | 7 | $104 |
| Myriad Women's Health, Inc. | 1 | $100 |
| Sumitomo Pharma America, Inc. | 4 | $93 |
| Pfizer | 5 | $82 |
| Merck | 4 | $78 |
| Mayne Pharma Commercial LLC | 4 | $76 |
| Coopersurgical, Inc. | 4 | $72 |
| Sage Therapeutics, LLC | 3 | $66 |
| Bayer | 5 | $62 |
| Shield Therapeutics Inc | 2 | $49 |
| Millicent US Inc | 2 | $40 |
| Exact Sciences | 2 | $39 |
| Mylan Pharmaceuticals Inc. | 3 | $37 |
| Hologic Sales And Service, LLC | 2 | $35 |
| Lupin Inc. | 2 | $26 |
| Dexcom, Inc. | 1 | $24 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
| Amgen | 1 | $12 |
| AMAG Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$3,190 in reported general payments places this provider in the 90th percentile of 195 obstetrics & gynecology providers in District of Columbia.
See all obstetrics & gynecology providers in District of Columbia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other obstetrics & gynecology in Washington
- Mark HathawayWashington$180K
- Renuka Darolia AdelizziWashington$72K
- Jovana TavcarWashington$5K
- Rachel ScottWashington$5K
- Jamila PerrittWashington$5K
- Stephanie HackWashington$4K
- Nicholas HazenWashington$4K
- Serina FloydWashington$4K
- Amr MadkourWashington$4K
- Peng YeWashington$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.